Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype

Fudan University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
mutationtriple-negative-breast-cancer
triple negative breast cancer, metastatic breast cancer, mutation, pi3k/akt/mtor mutation, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 852837
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.